QIANHAI HEALTH Stock (00911.HK) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

QIANHAI HEALTH

00911.HK

Qianhai Health Holdings Limited, an investment holding company, engages in the trading and sale of health-care products in Hong Kong. The company offers Chinese herbal medicines and other health care products; and administrative services. It also trades in ginseng wine and other healthy food products. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016.

29.31 B

00911.HKMarket value -Rank by Market Cap -/-

Financial Score

09/12/2025 Update

Technology DistributorsIndustry

Industry Ranking23/28

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreD
- ROE-2.40%D
- Profit Margin-1.71%D
- Gross Margin4.15%E
Growth ScoreE
- Revenue YoY-40.37%E
- Net Profit YoY-112.62%E
- Total Assets YoY-25.30%E
- Net Assets YoY-2.44%D
Cash ScoreE
- Cash Flow Margin-5849.96%E
- OCF YoY-40.37%E
Operating ScoreA
- Turnover1.21A
Debt ScoreA
- Gearing Ratio0.59%A

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Zhiqun Huang	0.1%	No Change	20/05/2024
Tzea Lim	0.1%	No Change	22/11/2024

News

New Concepts Holdings Extends Disposal Period for 51% Stake in Clear Industry Company

New Concepts Holdings Ltd. has extended the disposal period for its 51% stake in Clear Industry Company Limited by 12 months, now ending on 22 November 2026. This decision considers recent capital market conditions, share price performance, and market liquidity. All other terms remain unchanged.

Reuters·12/02/2025 19:30

Reuters·12/02/2025 19:30

New Concepts Holdings HY2025 EBITDA loss widens to HKD11.9 million, up over two times

New Concepts Holdings Ltd. reported a widened EBITDA loss of HKD 11.9 million for HY2025, more than doubling from the previous period. Revenue increased by 4.1% to HKD 377.2 million, while gross profit was HKD 25.3 million. The loss attributable to shareholders rose by 28.2% to HKD 19.0 million. No interim dividend was recommended.

Reuters·11/27/2025 22:38

Reuters·11/27/2025 22:38

New Concepts Holdings Acquires 12% Stake in Guangxi Ronghe Bioenergy for RMB24 Million

New Concepts Holdings Limited has acquired a 12% equity stake in Guangxi Ronghe Bioenergy Technology Co., Ltd. for RMB24 million. The transaction, classified as a discloseable transaction under Hong Kong Listing Rules, was executed on November 26, 2025, and involves an indirect wholly-owned subsidiary of New Concepts Holdings and Xiamen Nuohongsheng Trading Co., Ltd. This acquisition does not require shareholder approval but necessitates notification and announcement.

Reuters·11/26/2025 22:16

Reuters·11/26/2025 22:16